Ignite Creation Date:
2024-05-05 @ 11:53 PM
Last Modification Date:
2024-10-26 @ 10:41 AM
Study NCT ID:
NCT01446159
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2011-09-12
Brief Title:
Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Organization Data
Organization:
MedImmune LLC
Class:
INDUSTRY
Study ID:
CD-ON-MEDI-573-1030
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedImmune LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None